Table 4.
Differences in serum concentration of Gd-IgA1, miR-148, and let-7b and in Models 1 and 2 between patients with slow, moderate, and fast progression (SP, MP and FP, respectively).
| SP | MP | FP | p | |
|---|---|---|---|---|
| n | 15 | 24 | 22 | |
| Gd-IgA * | 1.55(0.9–4.8) | 1.28(0.4–4.2) | 1.1(0.3–4.1) | NS |
| miR-148b | 0.5(0.1–2.1) | 0.43(0.1–0.48) | 0.39(0.2–0.8) | NS |
| let7b | 3.24(0.4–32) | 1.7(0.4–38) | 10(0.3–53.8) | 0.01 |
| Model 1 | −0.52[(−3.3)–1.9] | −1.28[(−2.9)–3.1] | 1.1[(−2.8)–5.4] | 0.003 |
| Model 2 | −0.64[(−3.6)–2.4] | −1.26[(−3.4)–3.4] | 1.07[(−3.4)–5.3] | 0.005 |
* The levels of Gd-IgA1, miR-148b, let-7b, and Models 1 and 2, in patients and controls, are expressed as median and range. NS: Not Significant.